Loncastuximab Tesirine in a Frail, Heavily Pretreated Patient With Relapsed/Refractory Diffuse Large B‐Cell Lymphoma: A Case Report
ABSTRACT Loncastuximab tesirine may offer a feasible, well‐tolerated option for frail, heavily pretreated patients with relapsed/refractory DLBCL and poor performance status when intensive therapies are unsuitable, achieving durable remission with manageable fluid retention through careful monitorin...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wiley
2026-04-01
|
| Col·lecció: | Clinical Case Reports |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1002/ccr3.72234 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|